Table 1.
Patient demographics
| Characteristics | All patients (n = 134) | AC (n = 14) | EHC (n = 84) | HC (n = 21) | ICC(n = 15) |
|---|---|---|---|---|---|
| Age | 65.3 ± 8.9 | 66.0 ± 11.5 | 65.8 ± 8.4 | 63.5 ± 7.8 | 64.4 ± 10.7 |
| Male:Female | 94:40 | 11:3 | 60:24 | 13:8 | 10:5 |
| Diff. (W/M/P) | 68/44/22 | 11/3/0 | 38/27/19 | 15/4/2 | 4/10/1 |
| pT stage | |||||
| T1 | 10 | 3 | 5 | 2 | 0 |
| T2 | 63 | 6 | 27 | 18 | 12 |
| T3 | 57 | 5 | 48 | 1 | 3 |
| T4 | 4 | 0 | 4 | 0 | 0 |
| LN metastases | 62 | 4 | 46 | 7 | 5 |
| R0 resection | 79 | 13 | 51 | 7 | 8 |
AC, ampullary adenocarcinoma; Diff., differentiation; EHC, distal extrahepatic bile duct adenocarcinoma; HC, hilar cholangiocarcinoma; ICC, intrahepatic cholangiocarcinoma; LN, lymph node; M, moderately; P, poorly; W, well.